Updated on 11 January 2016
Access to Medicine Foundation, a non-profit organization based in the Netherlands, will visit Tokyo, Japan from January 12 to 15, 2016 for a series of meetings with Japan-based pharmaceutical companies and other key stakeholders working towards improving access to medicine worldwide.
As Japan's pharmaceutical industry opens up to the world, supported by the Japanese government reaffirming its commitment to global health, the foundation believes that this is a unique opportunity to build consensus, share ideas and drive progress on current access-to-medicine challenges.
The aim of the trip is to engage in strategic discussions on the roles of the pharmaceutical industry and other stakeholders in this space, and identify opportunities to support the global health agenda.
"Following other meetings with pharmaceutical companies measured in the Access to Medicine Index, we have seen how these discussions lead to a deeper understanding of our shared goals and an acceleration of companies' access approaches in developing markets. We have also seen the opening of stronger communication channels between companies and other stakeholders," says Jayasree K Iyer, Executive Director of the Access to Medicine Foundation.
The week will start with an access to medicine meeting involving a range of interested stakeholders, hosted by the Japan Pharmaceutical Manufacturers Association (JPMA). Jayasree K Iyer, Executive Director, and Suzanne Wolf, Director of Communications, will also meet with the leadership from the four Japan-based companies measured in the Access to Medicine Index - Astellas, Daiichi Sankyo, Eisai and Takeda - as well as with investors and government officials from several ministries with responsibility for global health issues.